InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak
NanoViricides, Inc. (NYSE American: NNVC) announced that its broad-spectrum antiviral, NV-387, may be a potential treatment for measles amid the ongoing outbreak. The company emphasized the urgency of addressing the lack of an approved antiviral for measles, aligning with recent remarks by HHS Secretary Robert F. Kennedy Jr. in a Fox News opinion piece. NV-387 has demonstrated efficacy against viruses that use heparan sulfate proteoglycans…